Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95): A trial of the Eastern Cooperative Oncology Group
- Friedenberg, W.R.
- Rue, M.
- Blood, E.A.
- Dalton, W.S.
- Shustik, C.
- Larson, R.A.
- Sonneveld, P.
- Greipp, P.R.
ISSN: 0008-543X, 1097-0142
Argitalpen urtea: 2006
Alea: 106
Zenbakia: 4
Orrialdeak: 830-838
Mota: Artikulua
